RECBIO-B: Form of Proxy for use at the 2023 Annual General Meeting to be held on Wednesday, May 8, 2024
RECBIO-B: 2023 Environmental, Social and Governance Report
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
RECBIO-B: Letter to Non-registered Shareholder - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
RECBIO-B: Letter to Registered Shareholder - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
RECBIO-B: VOLUNTARY ANNOUNCEMENT POSITIVE RESULTS IN THE INTERIM ANALYSIS OF THE CLINICAL TRIAL OF THE COMPANY''S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 IN THE PHILIPPINES
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
RECBIO-B: ARTICLES OF ASSOCIATION
RECBIO-B: Form of Proxy for use at the 2023 First H Share Class Meeting to be held on Thursday, September 21, 2023
RECBIO-B: Form of Proxy for use at the 2023 First Extraordinary General Meeting to be held on Thursday, September 21, 2023
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
RECBIO-B: PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
RECBIO-B: VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF CLINICAL TRIAL APPLICATION FOR THE COMPANY''S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 IN CHINA AND OVERSEAS CLINICAL TRIAL PROGRESS
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
No Data